Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,736 | 177 | 94.7% |
| Education | $205.78 | 4 | 5.2% |
| Travel and Lodging | $3.57 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $730.18 | 46 | $0 (2024) |
| PFIZER INC. | $685.43 | 27 | $0 (2023) |
| Janssen Biotech, Inc. | $410.09 | 14 | $0 (2024) |
| Incyte Corporation | $409.29 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $254.10 | 9 | $0 (2024) |
| Lilly USA, LLC | $246.32 | 8 | $0 (2023) |
| Biofrontera Inc. | $160.04 | 7 | $0 (2023) |
| Almirall LLC | $156.42 | 7 | $0 (2022) |
| UCB, Inc. | $133.82 | 6 | $0 (2024) |
| GENZYME CORPORATION | $114.96 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,038 | 58 | ABBVIE INC. ($319.78) |
| 2023 | $792.98 | 36 | ABBVIE INC. ($223.41) |
| 2022 | $1,540 | 65 | PFIZER INC. ($290.40) |
| 2021 | $574.56 | 23 | PFIZER INC. ($338.25) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $2.23 | General |
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Immunology | ||||||
| 08/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.60 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 927 | 1,850 | $212,642 | $50,534 |
| 2022 | 20 | 1,543 | 6,154 | $387,179 | $131,033 |
| 2021 | 15 | 1,069 | 2,506 | $246,873 | $81,091 |
| 2020 | 14 | 694 | 1,295 | $152,540 | $48,766 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 279 | 358 | $52,333 | $16,571 | 31.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 118 | $32,567 | $7,877 | 24.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 157 | 179 | $30,500 | $5,198 | 17.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 137 | 923 | $33,580 | $4,291 | 12.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 36 | 40 | $18,060 | $3,300 | 18.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $7,971 | $2,090 | 26.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 32 | $10,333 | $2,044 | 19.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 16 | $5,179 | $1,972 | 38.1% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 28 | 30 | $4,698 | $1,550 | 33.0% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 27 | 32 | $4,083 | $1,296 | 31.7% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 19 | 23 | $2,935 | $1,272 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 20 | $4,130 | $1,095 | 26.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 31 | $3,431 | $1,085 | 31.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 12 | $2,841 | $893.63 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 361 | 645 | $83,209 | $38,496 | 46.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 148 | 183 | $37,149 | $13,971 | 37.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 255 | 385 | $57,500 | $13,057 | 22.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 225 | 1,874 | $65,590 | $9,345 | 14.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 54 | 73 | $33,580 | $8,872 | 26.4% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 106 | 141 | $17,992 | $8,012 | 44.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 40 | 58 | $18,670 | $6,759 | 36.2% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2022 | 68 | 88 | $13,781 | $6,687 | 48.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $10,414 | $3,553 | 34.1% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2022 | 45 | 56 | $7,144 | $3,271 | 45.8% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2022 | 11 | 2,400 | $3,816 | $2,988 | 78.3% |
About Darin Kleinsmith, PA-C
Darin Kleinsmith, PA-C is a Physician Assistant healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2016. The National Provider Identifier (NPI) number assigned to this provider is 1275997629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Darin Kleinsmith, PA-C has received a total of $3,946 in payments from pharmaceutical and medical device companies, with $1,038 received in 2024. These payments were reported across 182 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,736).
As a Medicare-enrolled provider, Kleinsmith has provided services to 4,233 Medicare beneficiaries, totaling 11,805 services with total Medicare billing of $311,423. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Bala Cynwyd, PA
- Active Since 04/12/2016
- Last Updated 01/20/2026
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1275997629
Products in Payments
- EUCRISA (Drug) $523.00
- TREMFYA (Drug) $410.09
- SKYRIZI (Biological) $356.49
- OPZELURA (Drug) $353.15
- RINVOQ (Biological) $310.30
- DUPIXENT (Biological) $199.00
- LIBTAYO (Biological) $170.06
- CIBINQO (Drug) $162.43
- AMELUZ (Drug) $160.04
- Seysara (Drug) $106.03
- TALTZ (Drug) $97.49
- Otezla (Drug) $90.24
- Bimzelx (Biological) $84.10
- COSENTYX (Biological) $83.19
- DAXXIFY (Drug) $80.53
- BLU-U (Medical Supply) $63.53
- AKLIEF (Drug) $56.34
- Klisyri (Drug) $50.39
- Cimzia (Drug) $49.72
- HUMIRA (Biological) $35.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Bala Cynwyd
Amy Jones, Pac, PAC
Physician Assistant — Payments: $3,750
Zobaku Acholonu, Pa-C, PA-C
Physician Assistant — Payments: $1,278
Carly Liberatore
Physician Assistant — Payments: $527.37
Amanda Mcgurk, Pa, PA
Physician Assistant — Payments: $19.43